Phytel
1996
FOUNDED
M&A
STATUS
101-200
EMPLOYEES
M&A
LATEST DEAL TYPE
$232M
LATEST DEAL AMOUNT
Description
Provider of information technology services for physician communications and medical practice management. The company offers disease management and preventive care protocols that identify and notify non compliant patients of needed healthcare actions. It develops and maintains prescription, lab and clinical data for health and disease management. The company also offers systems integration, application development and reporting services.
Primary Industry
Enterprise Systems (Healthcare)
Acquirer
Primary Office
- 11511 Luna Road
- Suite 600
- Farmers Branch, TX 75234
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Phytel’s full profile, request a free trial.
Phytel Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 04-May-2015 | $232M | 000.00 | 00000 | Completed | Generating Revenue |
| 7. Later Stage VC (Series G) | 26-Aug-2013 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 6. Later Stage VC (Series F) | 27-Aug-2012 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 5. Later Stage VC (Series E) | 11-Feb-2010 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Later Stage VC (Series D) | 29-Sep-2008 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 3. Later Stage VC (Series C) | 24-Dec-2007 | 000 | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 07-Mar-2007 | $3.35M | $5.35M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 15-Apr-2005 | $2M | $2M | Completed | Generating Revenue |
Phytel Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series G | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series F | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 0.000 |
| Series E | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
| Series D | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series C | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 2,310,000 | $0.001000 | 7% | $1.45 | $1.45 | 1x | $1.45 | 11.56% |
| Series A | 2,000,000 | $0.001000 | 7% | $1 | $1 | 1x | $1 | 10% |
Phytel Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Caris Life Sciences | PE-Backed Company | Minority | 000 0000 | 000000 0 | ||
| Individual Investor | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Lah Investments | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Polaris Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Phytel Executive Team (18)
3 Former Executives
You’re viewing 5 of 18 executives. Get the full list »